Correlation Between Dr Reddys and Kiniksa Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Dr Reddys and Kiniksa Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dr Reddys and Kiniksa Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Dr Reddys Laboratories and Kiniksa Pharmaceuticals, you can compare the effects of market volatilities on Dr Reddys and Kiniksa Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dr Reddys with a short position of Kiniksa Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dr Reddys and Kiniksa Pharmaceuticals.

Diversification Opportunities for Dr Reddys and Kiniksa Pharmaceuticals

0.83

Correlation Coefficient

Dr Reddys  Kiniksa Pharmaceuticals

Very poor diversification

The 3 months correlation between RDY and Kiniksa is 0.83. Overlapping area represents the amount of risk that can be diversified away by holding Dr Reddys Laboratories and Kiniksa Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kiniksa Pharmaceuticals and Dr Reddys is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dr Reddys Laboratories are associated (or correlated) with Kiniksa Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kiniksa Pharmaceuticals has no effect on the direction of Dr Reddys i.e., Dr Reddys and Kiniksa Pharmaceuticals go up and down completely randomly.

Pair Corralation between Dr Reddys and Kiniksa Pharmaceuticals

Considering the 90-day investment horizon Dr Reddys Laboratories is expected to under-perform the Kiniksa Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Dr Reddys Laboratories is 2.27 times less risky than Kiniksa Pharmaceuticals. The stock trades about -0.17 of its potential returns per unit of risk. The Kiniksa Pharmaceuticals is currently generating about -0.07 of returns per unit of risk over similar time horizon. If you would invest  2,601  in Kiniksa Pharmaceuticals on August 31, 2024 and sell it today you would lose (393.00) from holding Kiniksa Pharmaceuticals or give up 15.11% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	98.44%
Values	Daily Returns

Dr Reddys Laboratories  vs.  Kiniksa Pharmaceuticals

Dr Reddys Laboratories

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Dr Reddys Laboratories has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's fundamental indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Kiniksa Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Kiniksa Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Dr Reddys and Kiniksa Pharmaceuticals

The main advantage of trading using opposite Dr Reddys and Kiniksa Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dr Reddys position performs unexpectedly, Kiniksa Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kiniksa Pharmaceuticals will offset losses from the drop in Kiniksa Pharmaceuticals' long position.

The idea behind Dr Reddys Laboratories and Kiniksa Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.